No matches

3 search results for: monitoring

Type 2 Inflammation

Clinical Manifestations Associated With Airway Remodeling in Asthma

2 min

expert video

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

Dermatology

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

5 min

Infographic

An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.

Dermatology

Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria

2 min

expert video

Tune in as Dr. Jason Hawkes describes how to assess disease activity in chronic spontaneous urticaria.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: JapanChange country/region